Universitaetsklinikum Tuebingen AöR

Tübingen 72076

3 studies enrolling now · 3 studies all time

What they study most

Locally Advanced Basal Cell Carcinoma, Multiple Myeloma

Studies at this site

• L19IL2 or L19TNF or L19IL2/TNF in Patients With Basal Cell Carcinoma (BCC) — Recruiting now
• L19IL2/TNF in Patients With Basal Cell Carcinoma — Recruiting now
• Phase 3 Study of Teclistamab in Combination With Lenalidomide and Teclistamab Alone Versus Lenalidomide Alone in Participants With Newly Diagnosed Multiple Myeloma as Maintenance Therapy Following Autologous Stem Cell Transplantation — Recruiting now